SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW

NCT05471440 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

431

Enrollment

OTHER

Sponsor class

Conditions

Covid-19 Vaccination

Interventions

DRUG: Direct boost mRNA
DRUG: Direct boost adeno
DRUG: Post-poned boost mRNA
DRUG: Post-poned boost adeno

Sponsor

Erasmus Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]